Market Segmentation
- U.S. In Vitro Diagnostics Product Outlook (Volume, Number of Tests and Instruments; Revenue, USD Billion, 2018 - 2030)
- Instruments
- Reagents
- Services
- U.S. In Vitro Diagnostics Technology Outlook (Volume, Number of Tests and Instruments; Revenue, USD Billion, 2018 - 2030)
- Immunoassays
- Instruments
- Reagents
- Services
- Hematology
- Instruments
- Reagents
- Services
- Clinical Chemistry
- Instruments
- Reagents
- Services
- Molecular Diagnostics
- Instruments
- Reagents
- Services
- Coagulation
- Instruments
- Reagents
- Services
- Microbiology
- Instruments
- Reagents
- Services
- Others
- Instruments
- Reagents
- Services
- Immunoassays
- U.S. In Vitro Diagnostics Application Outlook (Revenue, USD Billion, 2018 - 2030)
- Infectious Diseases
- Upper respiratory
- Gastrointestinal panel testing
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Clostridium difficile
- Vancomycin-Resistant Enterococci (VRE)
- Carbapenem-resistant bacteria
- Flu
- Respiratory Syncytial Virus (RSV)
- Candida
- Tuberculosis (TB) and drug-resistant TB
- Meningitis
- Chlamydia
- Gonorrhoea
- HIV
- Hepatitis C
- Hepatitis B
- Other infectious disease
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Diseases
- Drug Testing
- Hematologic Diseases
- Others
- Infectious Diseases
- U.S. In Vitro Diagnostics Test location Outlook (Revenue, USD Billion, 2018 - 2030)
- Point of Care
- Home-care
- Others
- U.S. In Vitro Diagnostics End Use Outlook (Volume, Number of Tests and Instruments; Revenue, USD Billion, 2018 - 2030)
- Hospitals
- Immunoassays
- Instruments
- Reagents
- Services
- Hematology
- Instruments
- Reagents
- Services
- Clinical Chemistry
- Instruments
- Reagents
- Services
- Molecular Diagnostics
- Instruments
- Reagents
- Services
- Coagulation
- Instruments
- Reagents
- Services
- Microbiology
- Instruments
- Reagents
- Services
- Others
- Immunoassays
- Laboratories
- Immunoassays
- Instruments
- Reagents
- Services
- Hematology
- Instruments
- Reagents
- Services
- Clinical Chemistry
- Instruments
- Reagents
- Services
- Molecular Diagnostics
- Instruments
- Reagents
- Services
- Coagulation
- Instruments
- Reagents
- Services
- Microbiology
- Instruments
- Reagents
- Services
- Others
- Immunoassays
- Home-care
- Immunoassays
- Instruments
- Reagents
- Services
- Hematology
- Instruments
- Reagents
- Services
- Clinical Chemistry
- Instruments
- Reagents
- Services
- Molecular Diagnostics
- Instruments
- Reagents
- Services
- Coagulation
- Instruments
- Reagents
- Services
- Microbiology
- Instruments
- Reagents
- Services
- Others
- Immunoassays
- Others
- Hospitals
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Country market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Country market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
